Literature DB >> 3855294

Control of HL-60 myeloid differentiation. Evidence of uncoupled growth and differentiation control, S-phase specificity, and two-step regulation.

A Yen.   

Abstract

Myeloid differentiation of HL-60 human promyelocytic leukemia cells was studied during DMSO-induced differentiation. G 1/0-specific growth arrest could occur without the usual associated subsequent phenotypic differentiation into mature myeloid cells, suggesting that growth arrest and phenotypic differentiation are separately regulated. In the course of differentiating, the cells achieved a semi-stable intermediate state where they had a labile, pre-commitment memory of exposure to inducer, but were not yet committed to differentiation. This state was associated with a nuclear structural change previously found to be associated with the precommitment memory state. The process of differentiation could thus be resolved into two steps, early events up through development of pre-commitment memory and late events subsequents to pre-commitment memory. The kinetics of terminal cell differentiation indicated that the cellular regulatory event initiating a program of differentiation in response to inducer was S phase-specific. A comparison of the present results for DSMO to previous results for retinoic acid (RA)-induced HL-60 myeloid differentiation showed that the two inducers effect different cellular pathways for differentiation of HL-60 cells to mature myeloid cells, but with certain common features including the above S-phase specificity and pre-commitment memory.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3855294     DOI: 10.1016/0014-4827(85)90274-5

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  10 in total

1.  Arginine methylation provides epigenetic transcription memory for retinoid-induced differentiation in myeloid cells.

Authors:  Balint L Balint; Attila Szanto; Andras Madi; Uta-Maria Bauer; Petra Gabor; Szilvia Benko; Laszlo G Puskás; Peter J A Davies; Laszlo Nagy
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

2.  1,25-Dihydroxy vitamin D2 induces leukemia cell differentiation.

Authors:  A Yen; J Blue; M Forbes
Journal:  In Vitro Cell Dev Biol       Date:  1991-07

3.  Colony stimulating factor-induced differentiation of murine M1 myeloid leukemia cells is permissive in early G1 phase.

Authors:  H Tsuda; L M Neckers; D H Pluznik
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

4.  Two distinct mechanisms of transcriptional control operate on c-myc during differentiation of HL60 cells.

Authors:  U Siebenlist; P Bressler; K Kelly
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

5.  An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation.

Authors:  J T Holt; R L Redner; A W Nienhuis
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

6.  Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells.

Authors:  J Schwaller; H P Koeffler; G Niklaus; P Loetscher; S Nagel; M F Fey; A Tobler
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

7.  Immunocytochemistry of apoptosis induced by bromodeoxyuridine in human leukemic HL-60 cells.

Authors:  K Kondo; T Makita
Journal:  Jpn J Cancer Res       Date:  1997-01

Review 8.  The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.

Authors:  A C Sartorelli
Journal:  Br J Cancer       Date:  1985-09       Impact factor: 7.640

9.  Changes in c-myc expression and the kinetics of dexamethasone-induced programmed cell death (apoptosis) in human lymphoid leukaemia cells.

Authors:  A C Wood; C M Waters; A Garner; J A Hickman
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

10.  Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression.

Authors:  A C Wood; P Elvin; J A Hickman
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.